MBC BioLabs Announces New Partnership with Araceli Biosciences

[San Francisco, CA – October 29, 2025] – MBC BioLabs is launching a new partnership with Araceli Biosciences to support its mission of supporting its community of start-up founders and scientists.

About Araceli Biosciences

Araceli Biosciences is on a mission to transform therapeutic discovery with technologies built for speed, precision, and impact. Our advanced High Content Imaging platforms deliver real-time analysis, providing researchers with immediate, actionable answers during experiments. This ability to respond at the pace of biology accelerates decision-making, improves candidate selection, and reduces costly downstream failures.

At the same time, our platforms generate high-quality, analysis-ready data that feed into AI-driven models and discovery pipelines. This dual advantage, instant insights today and predictive power tomorrow, positions Araceli as the catalyst for faster, more confident therapeutic breakthroughs. We believe in a future where patients gain access to the most effective treatments sooner, and Araceli is making that future real.

Learn more about Araceli Biosciences here.

About MBC BioLabs

MBC BioLabs is dedicated to helping life-science startups succeed – we like to say that we enable awesome. We have helped launch and grow over 500 companies in our labs since opening in October of 2013, and these companies have gone on to raise over $20B! Our program allows companies to be fast, focused, and frugal. You can rent space as small as a single bench in class-A lab space and access hourly use of millions of dollars of equipment.

We operate out of five locations: 953 Indiana St., San Francisco, 135 Mississippi St., San Francisco, 733 Industrial Rd., 930 Brittan Ave., and 1030 Brittan Ave., San Carlos and all our labs are BSL-2.